The Motley Fool

Key Data Points

Primary metrics and data points about Protalix BioTherapeutics, Inc..
Current Price: $2.18
Prev Close: $2.22
Open: $2.25
Bid: $2.13
Ask: $2.36
Day's Range: $2.14 - $2.25
52wk Range: $1.53 - $4.20
Volume: 560,385
Avg Vol 285,603
Market Cap: $204M
P/E (ttm): -6.53
EPS (ttm): ($0.34)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Protalix BioTherapeutics, Inc. from Fool.com.

Business Summary

Industry, sector and description for Protalix BioTherapeutics, Inc..

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

PLX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Protalix BioTherapeutics, Inc..
CAPS Rating 2 out of 5
 
164 Outperform
72 Underperform
CAPS All Stars
 
32 Outperform
23 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

David Aviezer, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Protalix BioTherapeutics, Inc.

Primary metrics and data points about Protalix BioTherapeutics, Inc..